Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 8:10:267.
doi: 10.1186/1471-2407-10-267.

The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes

Affiliations

The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes

Hok Kwok Choi et al. BMC Cancer. .

Abstract

Background: Lymph node status is the most important prognostic factor for colorectal cancer. The number of lymph nodes that should be histologically examined has been controversial. The aims of this study were to assess the impact of the number of lymph nodes examined on survival of patients with stage II colorectal cancer and to determine the optimal number of lymph nodes that should be examined.

Methods: The study included 664 patients who underwent resection for stage II colorectal cancer. The clinical and histopathologic data of the patients were prospectively collected and analyzed.

Results: The median number of lymph nodes examined was 12 (range: 1 to 58). The 5-year disease free survival rate was significantly higher for patients with 12 or more lymph nodes examined compared to those with less than 12 lymph nodes examined. The significant difference in 5-year disease free survival persisted if the dividing number increased progressively from 12 to 23. However, the difference in survival was most significant (lowest p value and highest hazard ratio) for the number 21. The 5-year disease free survival of patients with 21 or more lymph nodes examined was 80% whereas that of patients with less than 21 lymph nodes examined was 60% (p = 0.001, hazard ratio 2.08). Multivariate analysis showed that 21 or more lymph nodes examined was a factor that independently influenced survival. The 5-year disease free survival also increased progressively with the number of lymph node examined up to the number 21. After the number 21, the survival rate did not increase further. It was likely that 21 was the optimal number, at and above which the chance of lymph node metastasis was minimal.

Conclusions: The number of lymph nodes examined in colorectal cancer specimen significantly influences survival. It is recommended that at least 21 lymph nodes should be examined for accurate diagnosis of stage II colorectal cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disease free survival of all the 664 patients.
Figure 2
Figure 2
Disease free survival of patients with at least 21 and less than 21 lymph nodes examined.

Similar articles

Cited by

References

    1. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ. The benefits of leucovorin - modulated fluorouracil as postoperative therapy for primary colon cancers: results from the National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol. 1993;11:1879–87. - PubMed
    1. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D. National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583–96. doi: 10.1093/jnci/93.8.583. - DOI - PubMed
    1. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal cancinoma before and after fat clearance. Br J Surg. 1989;76:1165–7. doi: 10.1002/bjs.1800761118. - DOI - PubMed
    1. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR, Newland RC. Clinicopathologic staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT) J Gastroenterol Hepatol. 1991;6:325–44. doi: 10.1111/j.1440-1746.1991.tb00867.x. - DOI - PubMed
    1. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gómez-Fleitas M. Colorectal adenocarcnoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37:373–7. doi: 10.1007/BF02053600. - DOI - PubMed

MeSH terms